Asia Pacific sports medicine market will grow by 9.1% annually with a total addressable market cap of $23.25 billion over 2020-2030 owing to the rising incidents of sports injuries, consistent innovation of new products and treatment modalities, and growing healthcare expenditure.
Highlighted with 39 tables and 55 figures, this 125-page report Asia Pacific Sports Medicine Market 2020-2030 by Product (Repair, Recovery, Monitoring, Accessories), Application (Knee, Shoulder, Hip), End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific sports medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific sports medicine market in every aspect of the classification from perspectives of Product, Application, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Body Reconstruction and Repair Devices
Fracture and Ligament Repair Devices
Implants
Arthroscopy Devices
Repair Devices
Orthobiologics
Prosthetics
Body Support and Recovery Devices
Braces and Supports
Physiotherapy
Compression Clothing
Topical Pain Relief
Other Body Support and Recovery Devices
Body Monitoring and Evaluation Devices
Cardiac Monitoring Devices
Respiratory Monitoring Devices
Hemodynamic Monitoring Devices
Musculoskeletal Monitoring Devices
Other Monitoring/Evaluation Devices
Accessories

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Knee Injury
Orthobiologic Devices
Suture Anchors
Meniscal Repair
Arthroscopy Devices
Fixation Devices
Ligament Reconstruction Systems
Other Knee Injury Devices
Shoulder Injury
Suture Anchors and Management System
Arthroscopy Devices
Orthobiologic & Biologic Implant
Other Shoulder Injury Products
Hip Injury
Suture Anchor and Management Systems
Arthroscopy Devices
Other Hip Injury Products
Foot and Ankle Injury
Implants and Screws
Fixation Systems
Orthobiologic Devices
Elbow and Wrist Injury
Implants and Screws
Orthobiologic Devices
Other Injuries

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Hospitals
Ambulatory Surgery Centers
Physiotherapy Centers and Clinics
Other End Users

Geographically, the following national/local markets are fully investigated:
Japan
China
South Korea
Australia
India
Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific sports medicine market are assayed quantitatively and qualitatively through GMDs Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Arthrex Inc.
Bioventus LLC
Breg, Inc.
Ceterix Orthopaedics Inc.
ConMed Corporation
DJO, LLC
Johnson & Johnson
Mueller Sports Medicine, Inc.
Osiris Therapeutics, Inc.
RTI Surgical, INC.
Smith & Nephew plc
Stryker Corporation
Wright Medical Group N.V.
Zimmer Biomet Holdings Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)